MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-MP-24-0008414
Denice Pharmaceuticals Private Limited
Denice Pharmaceuticals Private Limited - trading in Jabalpur, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹5.92 Lakh
▲ 91% YoY
Net loss · FY 2022
₹954
Net margin -0.2%
EBITDA · FY 2022
₹5,531
EBITDA margin 0.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
GST registrations
1
None active
About Denice Pharmaceuticals Private Limited
Data last updated:
Denice Pharmaceuticals Private Limited is a private limited company based in Jabalpur, Madhya Pradesh, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 06 December 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24233MP2013PTC031906. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anil Kumar and Ranjana Singh.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at House No. 266/B Behind Royal Hospital Kamla Nehru Nagar, Jabalpur, Madhya Pradesh, India – 482002.
As per the financials filed for FY 2022, the company reported a revenue of ₹5.92 Lakh, a growth of 91% compared to the previous year. For the same year it recorded a net loss of ₹954 (net margin -0.2%) and EBITDA of ₹5,531 (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 36% over five years.
Denice Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-24-0008414). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24233MP2013PTC031906
Registration Number 031906
Incorporation Date 06 December 2013
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MP-24-0008414
Key People
Anil Kumar Director Ranjana Singh Director Recognitions & Rankings of Denice Pharmaceuticals
Contact details
Denice Pharmaceuticals Private Limited's registered office is in Jabalpur, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No. 266/B Behind Royal Hospital Kamla Nehru Nagar, Jabalpur, Madhya Pradesh, India – 482002
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Denice Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Denice Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Denice Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Denice Pharmaceuticals Private Limited, buy the company report.
Financials of Denice Pharmaceuticals Private Limited
FY 2022 filings availableDenice Pharmaceuticals Private Limited reported revenue of ₹5.92 Lakh (up 91% YoY) for FY 2022.
Revenue · FY 2022
₹5.92 Lakh ▲ 91%
Net loss · FY 2022
₹954 margin -0.2%
EBITDA · FY 2022
₹5,531 margin 0.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 91%
3 years · compounded
▲ 16%
5 years · compounded
▲ 36%
EBITDA CAGR growth
1 year
▲ 103%
3 years · compounded
▼ 12%
5 years · compounded
▲ 19%
Revenue has grown at a compounded annual rate (CAGR) of 36% over five years, including 91% growth in the latest year. EBITDA rose 103% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5,531 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹954 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | -0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Denice Pharmaceuticals Private Limited, buy the company report.
Board of directors of Denice Pharmaceuticals Private Limited
Denice Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar | Director | 06 Dec 2013 | 12 Years 10 Months | Current |
| Ranjana Singh | Director | 25 Nov 2018 | 7 Years 11 Months | Current |
Peer comparison
Denice Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Novarance Pharmaceuticals Private Limited | ₹6 Lakh (FY 2025) | 73.0% | Mirzapur, Uttar Pradesh, India | |||
| Riedeli Pharmaceuticals Private Limited | ₹5.95 Lakh (FY 2024) | -1.0% | Allahabad, Uttar Pradesh, India | |||
| Denice Pharmaceuticals Private Limitedthis company | ₹5.92 Lakh (FY 2022) | -₹954 | -0.2% | 91.0% | Jabalpur, Madhya Pradesh, India | |
| Microsys Pharmaceuticals Private Limited | ₹5.9 Lakh (FY 2022) | -9.0% | Hathras, Uttar Pradesh, India | |||
| Gyrus Pharmaceuticals Private Limited | ₹5.85 Lakh (FY 2025) | 21.0% | Amritsar, Punjab, India |
To see the full peer comparison of Denice Pharmaceuticals Private Limited, buy the company report.
Auditor
Denice Pharmaceuticals Private Limited is audited by VIJAY RAMCHANDRA & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIJAY RAMCHANDRA & ASSOCIATES | FY 2017 | 010872C |
Shareholding
The shareholding of Denice Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Denice Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Denice Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Denice Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Denice Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
To see the full GST registrations and return filing status of Denice Pharmaceuticals Private Limited, buy the company report.
Recent activity
Denice Pharmaceuticals Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Priya Ranjan Kumar ceased to be Managing Director on 25 Nov 2018.
AGM
Denice Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Denice Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Gwalior.
Ceased
Priya Ranjan Kumar ceased to be Managing Director.
Appointed
Ranjana Singh was appointed as Director.
Appointed
Anil Kumar was appointed as Director.
Incorporation
06 Dec 2013
Denice Pharmaceuticals Private Limited was registered on 06 Dec 2013 with Roc Gwalior & aged 12 years 10 months as per MCA records.
Frequently asked questions
Denice Pharmaceuticals is an active private limited company based in Jabalpur, Madhya Pradesh, India. The company works in wholesale, within the trading industry. It was incorporated on 06 December 2013 (13+ years old) and is registered under CIN U24233MP2013PTC031906.
Denice Pharmaceuticals has 2 current directors:
- Anil Kumar - Director
- Ranjana Singh - Director
The latest financial statements of Denice Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
No. Denice Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Denice Pharmaceuticals is U24233MP2013PTC031906. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Denice Pharmaceuticals was incorporated on 06 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Denice Pharmaceuticals by revenue are Novarance Pharmaceuticals Private Limited, Riedeli Pharmaceuticals Private Limited, Microsys Pharmaceuticals Private Limited, Gyrus Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Priya Ranjan Kumar ceased to be Managing Director on 25 Nov 2018. Ranjana Singh was appointed as Director on 25 Nov 2018. Anil Kumar was appointed as Director on 06 Dec 2013.
Yes, Denice Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-24-0008414).
The registered office of Denice Pharmaceuticals is at House No. 266B Behind Royal Hospital Kamla Nehru Nagar, Jabalpur, Madhya Pradesh, India – 482002.
Denice Pharmaceuticals operates in the trading industry, in the wholesale segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages